{
  "title": "HIV Miracle Cure?",
  "description": "At the end of 2017, an estimated 36.9 million people were living with HIV. This week, a shocking medical discovery was announced that's grabbing the world's attention and sparking hope in the battle against the deadly disease. A London cancer patient treated with stem-cell transplants is now resistant to HIV. David Meyers speaks to the editor of Bloomberg's U.S. healthcare team Drew Amrstrong about on whether this is a miracle cure or just a piece in a very large puzzle. \nFOLLOW UP\nYou can follow Drew at: @ArmstrongDrew\n----\nTicToc is a daily news podcast hosted by David Meyers (@davidfmeyers), produced at Bloomberg Worldwide HQ in New York City. You can follow up with us and watch our reporting @tictoc. If you like it, be sure to rate us on iTunes, and tell your friends!",
  "pubDate": "Tue, 05 Mar 2019 22:00:00 -0000",
  "itunes:episodeType": "full",
  "itunes:author": "Bloomberg",
  "itunes:subtitle": "with Drew Armstrong (Bloomberg News)",
  "itunes:summary": "At the end of 2017, an estimated 36.9 million people were living with HIV. This week, a shocking medical discovery was announced that's grabbing the world's attention and sparking hope in the battle against the deadly disease. A London cancer patient treated with stem-cell transplants is now resistant to HIV. David Meyers speaks to the editor of Bloomberg's U.S. healthcare team Drew Amrstrong about on whether this is a miracle cure or just a piece in a very large puzzle. \nFOLLOW UP\nYou can follow Drew at: @ArmstrongDrew\n----\nTicToc is a daily news podcast hosted by David Meyers (@davidfmeyers), produced at Bloomberg Worldwide HQ in New York City. You can follow up with us and watch our reporting @tictoc. If you like it, be sure to rate us on iTunes, and tell your friends!",
  "content:encoded": "<p>At the end of 2017, an estimated 36.9 million people were living with HIV. This week, a shocking medical discovery was announced that's grabbing the world's attention and sparking hope in the battle against the deadly disease. A London cancer patient treated with stem-cell transplants is now resistant to HIV. David Meyers speaks to the editor of Bloomberg's U.S. healthcare team Drew Amrstrong about on whether this is a miracle cure or just a piece in a very large puzzle. </p><p><strong>FOLLOW UP</strong></p><p>You can follow Drew at: <a href=\"https://twitter.com/ArmstrongDrew\"><strong>@</strong>ArmstrongDrew</a></p><p>----</p><p><em>TicToc is a daily news podcast hosted by David Meyers (</em><a href=\"https://twitter.com/davidfmeyers\"><em>@davidfmeyers</em></a><em>), produced at Bloomberg Worldwide HQ in New York City. You can follow up with us and watch our reporting </em><a href=\"https://twitter.com/tictoc\"><em>@tictoc</em></a><em>. If you like it, be sure to </em><a href=\"https://itunes.apple.com/us/podcast/tictoc-by-bloomberg/id1377448815?mt=2\"><em>rate us on iTunes</em></a><em>, and tell your friends!</em></p>",
  "itunes:duration": 610,
  "guid": "98043ea4-3f6f-11e9-941a-5759899bcb6d",
  "enclosure": ""
}